Navigation Links
Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis
Date:4/3/2013

keting approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding the discovery, development, activity, therapeutic potential and safety of ISIS-APOARx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2012, which is on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, I
'/>"/>

SOURCE Isis Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
2. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
3. Alliqua Initiates Life-Cycle Management Plan to Expand Wound Care Portfolio for Use in Broader Wound Indications
4. Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat
5. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
6. NxStage Initiates 2013 Call to Action Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life
7. Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting
8. Nanomix Initiates Clinical Testing of Point of Care IVD Cardiac Panel
9. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
10. uniQure Initiates Phase I in Acute Intermittent Porphyria
11. Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data Solutions ... new website design . The main website, along with ... the company,s new services and content relevant to the ... new streamlined design, viewers can now better understand how ... care practices and create a more visible platform about ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... shareholders held in Hong Kong today. ... proposed by the Company: 1. THAT ...
... Masimo (NASDAQ: MASI ) announced today that ... October 1, 2011, after the market closes on October 25, 2011. ... p.m. PT (4:30 p.m. ET) and will be hosted by Joe ... Executive Vice President and Chief Financial Officer. A live ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
(Date:8/30/2014)... 31, 2014 Fast hosting is ... Top10BestSEOHosting.com has recently compared many professional web hosting ... ) and Arvixe are the suppliers of fastest ... to find a good fast hosting supplier. Actually, ... features, uptime, server speed and customer support. People ...
(Date:8/30/2014)... August 30, 2014 Information supplied by ... to introduce better prices to consumers in 2014. A ... be found when using the open system for adults ... system available to use this year can help the ... on general location and not from medical histories. The ...
(Date:8/30/2014)... Daily Gossip reveals in its review a program created by ... shows a unique formula to get inside a man’s mind ... the program goes beyond mere attraction and actually helps ladies ... that the program was created by dating expert Alex Carter, ... make a man feel emotionally addicted. , Learn more about ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... combination of Nutrition and Pharameuticals. Nutraceuticals is a ... extracting healthy ingredients from natural food sources. Nutraceutical ... health benefits to the human body. Nutraceutical health ... diet supplements, fortified foods and more. Although nature ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy treatments ... several years, Dr. Roy Schmidt and the staff ... scholarship program for veterans who have been diagnosed ... this summer to discuss veterans’ needs ( http://www.prweb.com/releases/2014/06/prweb11954058.htm ... light on the large number of veterans who ...
Breaking Medicine News(10 mins):Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2
... Houston - The University of Texas MD Anderson Cancer Center ... Academy of Sciences (NAS) - one of the most prestigious ... science and engineering. DePinho is the first member of ... The NAS is a private, nonprofit society of ...
... Cone beam CT is superior to mutidetector CT for detecting superior ... hole in the bony wall of the inner ear bone that ... radiation dose, a new study shows. , The study, conducted in ... CT and a multidetector CT examination of their right and left ...
... Over the past decade, there has been a steady ... oil capsules. According to Dr. Louise Moist, a Scientist ... improve outcomes for kidney patients undergoing hemodialysis. ... vessels created to join an artery to a vein. ...
... School of Medicine have gained insight into the mechanism ... to the progression of Alzheimer,s disease (AD) and other ... issue of the Journal of Biological Chemistry, ... to prevent tau from damaging brain circuits involved in ...
... May 1 (HealthDay News) -- A combination of moderate exercise ... risk of age-related memory loss more than computer use or ... in the May issue of Mayo Clinic Proceedings , ... 70 to 93, who completed questionnaires about their computer use ...
... the signaling pathways active in sarcomas, researchers at Moffitt ... a family of protein enzymes that act as "on" ... The tyrosine kinases they identified, the researchers said, could ... sarcomas. Sarcomas are relatively rare forms of cancer. ...
Cached Medicine News:Health News:UT MD Anderson President Ronald DePinho elected to National Academy of Sciences 2Health News:Everyday fish oil capsule may provide kidney-related benefits 2Health News:Researchers gain better understanding of mechanism behind tau spreading in the brain 2Health News:Exercise Plus Computer Time May Boost Seniors' Brains 2Health News:Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival 2
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Endotracheal Tube - Soft red rubber. Silkolatex™ coated. Silkolatex™ cuff. Magill tip - oral. Graduated. X-ray opaque....
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St...
Medicine Products: